Arena Pharmaceuticals (ARNA) Slammed on Massive 'Bear Raid'
Tweet Send to a Friend
Up)
The biggest momo stock in the market Arena Pharmaceuticals (Nasdaq: ARNA) was just the target of a massive "bear raid."
Shares plunged as low as $7.80, or down 33%, before recovering.
There is no new news, but with the 6/27 PDUFA date fast approaching investors are getting nervous with the current news vacuum.
This has been seen before in stocks like Dendreon Corp. (Nasdaq: DNDN) days before FDA approval was ultimately granted.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Shares plunged as low as $7.80, or down 33%, before recovering.
There is no new news, but with the 6/27 PDUFA date fast approaching investors are getting nervous with the current news vacuum.
This has been seen before in stocks like Dendreon Corp. (Nasdaq: DNDN) days before FDA approval was ultimately granted.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Yahoo! (YHOO) Board Said to Approve $1.1B Tumblr Deal
- Friday's Hot IPOs Get Even Hotter (MKTO) (DATA)
- UPDATE: Student Loan Rates Set for Change; ITT (ESI) & Corinthian (COCO) on Move
Create E-mail Alert Related Categories
Momentum Movers, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
